Saisei Mirai Group

Saisei Mirai Group is a Japanese medical organization specializing in integrative oncology and advanced immunotherapy. The group is globally recognized for its development and clinical application of GcMAF (Macrophage Activating Factor) and various cell-based therapies, including Dendritic Cell and NK Cell treatments. Operating several clinics across Japan and collaborating internationally, Saisei Mirai focuses on combining conventional treatments with complementary therapies like hyperthermia and high-dose Vitamin C. Their approach targets late-stage cancer and chronic viral infections through personalized immune system modulation. The group also engages in the production of specialized biological products in their own cell processing facilities.